Clinical Trial

Intermittent Low Oxygen Breathing: A First Study Testing Different Disease Stages in People Living With MS

Study acronym: LOxyMS
Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study will look at the safety, tolerability and feasibility of a non-invasive treatment called Acute Intermittent Hypoxia (AIH) in people with Multiple Sclerosis (MS) at different stages of the disease course.
Trial Details
NCT Number NCT07631143
Lead Sponsor University of Saskatchewan
Conditions Multiple Sclerosis
Enrollment 9 participants
Start Date 2026-07-01
Primary Completion 2028-08-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-05